Day One Biopharma Expands to ADCs with $55M Drug Acquisition
"Day One Biopharmaceuticals enhances pipeline, acquiring global rights to promising PTK7-targeting cancer drug DAY301, begins trial soon."
- Latest
- Trending
"Day One Biopharmaceuticals enhances pipeline, acquiring global rights to promising PTK7-targeting cancer drug DAY301, begins trial soon."
China's gold jewelry demand experienced a 10% increase, while India's demand fell by 6%. The country's appetite for gold is ...
China's blockchain initiative aims to strengthen trade ties globally by creating a public blockchain infrastructure platform for developing applications. This ...
NaaS expects sustained growth and margin improvement in the Chinese EV charging market. Fast-growing numbers indicate user stickiness, while a ...
Notable Capital renames its U.S. team, while Granite Asia appoints new leaders. Oren Yunger joins GGV Capital as managing director.
Dive into the financial insights of Yum China Holdings Inc, a powerhouse in the fast-food sector, offering a peek at ...
The Shanghai Composite index rose 1% to 3,041.17 while the SET in Bangkok increased by 0.5%. The S&P 500 reached ...
Deposits on the Ethereum blockchain have surpassed withdrawals as the price of ETH rises. With users participating in governance and ...
Shanghai Rongsheng Biotech Co., Ltd. and GSK have joined forces to develop a new adjuvant vaccine in Shanghai, signing a ...
Customers in China who purchase existing inventories of Tesla's Model 3 sedans and Model Y SUVs by the end of ...
We are building the future together with you. We write content with maximum speed and excellent quality. Each material is accompanied by an analyst's commentary.